The MOLES System for Planning Management of Melanocytic Choroidal Tumors: Is It Safe?
Kelsey A RoelofsRoderick O'DayLamis Al HarbyAmit K AroraVictoria M L CohenMandeep S SagooBertil DamatoPublished in: Cancers (2020)
The MOLES scoring system is a sensitive (99.8%) tool for indicating malignancy in melanocytic choroidal tumors (MOLES ≥ 3). If the examining practitioner can recognize the five features suggestive of malignancy, MOLES is a safe tool to optimize referral of melanocytic choroidal tumors for specialist care.